ArticleJournal of immunology (Baltimore, Md. : 1950)2021
Identification and Characterization of Antigen-Specific CD8
Open access · bronzeAbstract read
In one paragraph
Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 9 citations in OpenAlex.
- T cell antigenic recognition sequencing (TAR-seq) enables precise characterization of vaccine-elicited cellular immunity ex vivo andFrontiers in immunology · 2026Article
- Identification of antigen-specific functional CD8iScience · 2025Article
- Article
- Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8Science immunology · 2024Article
- CD4Nature immunology · 2024Article
- Identification and characterization of the T cell receptor (TCR) repertoire of the cynomolgus macaque (Macaca Fascicularis).BMC genomics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 6 institutions in 2 countries.
Shaheed AbdulhaqqVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.
Abigail B VenturaVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0002-8893-4769
Jason S ReedVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.
Arman A BashirovaBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD.
Katherine B BatemanVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.
Eric McDonaldVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0002-3203-4518
Helen L WuVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0001-7101-5160
Justin M GreeneVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0001-5690-8921
John B SchellVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0001-6707-7051
David MorrowVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0003-4686-830X
Karin WisskirchenInstitute of Virology, Technical University of Munich/Helmholtz Zentrum Munich, Munich, Germany.
Jeffrey N MartinDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-9773-3256
Steven G DeeksHIV/AIDS Program, Department of Medicine, University of California, San Francisco, San Francisco, CA.ORCID 0000-0001-6371-747X
Mary CarringtonBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD.ORCID 0000-0002-2692-2180
Ulrike ProtzerInstitute of Virology, Technical University of Munich/Helmholtz Zentrum Munich, Munich, Germany.ORCID 0000-0002-9421-1911
Klaus FrühVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0001-8014-3877
Scott G HansenVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.
Louis J PickerVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.ORCID 0000-0003-0546-398X
Jonah B SachaVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR; bimber@ohsu.edu sacha@ohsu.edu.ORCID 0000-0002-7633-3122
Benjamin N BimberOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR bimber@ohsu.edu sacha@ohsu.edu.ORCID 0000-0001-8092-3080
Oregon Health & Science University · USHelmholtz Zentrum München · DEOregon National Primate Research Center · USUniversity of California, San Francisco · USFrederick National Laboratory for Cancer Research · USRagon Institute of MGH, MIT and Harvard · US
Funding
Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9MUnsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4MVirology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6MA nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearanceR01AI129703 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI SACHA, JONAH B. · 2017 to 2025
$7.8MEvasion of Antigen Presentation by Rhesus CytomegalovirusR01AI059457 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI FRUH, KLAUS J · 2005 to 2021
$6.2MUnderstanding Unconventional CD8+ T cell Responses in Protection from HIVR01AI140888 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HANSEN, SCOTT G, SACHA, JONAH B. · 2018 to 2023
$4.4MNon-canonical epitope presentation and antigen processing by MHC-ER01AI175459 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Klaus J Fruh, Jonah B. Sacha · 2023 to 2026
$2.8MAdvancing MHC-E-Restricted T cells as a Universal ImmunotherapeuticK01OD029804 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI ABDULHAQQ, SHAHEED A. · 2020 to 2020
$111kCCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI059457NIAID NIH HHS R01 AI129703NIAID NIH HHS R01 AI140888NIAID NIH HHS R01 AI175459NIAID NIH HHS R24 AI067039NIH HHS K01 OD029804NIH HHS P51 OD011092
Abstract
CD8
Indexed as
CD8-Positive T-LymphocytesHIV InfectionsAnimalsEpitopesEpitopes, T-LymphocyteMacaca mulattaReceptors, Antigen, T-CellTumor Necrosis Factor-alphaEpitopesEpitopes, T-LymphocyteReceptors, Antigen, T-CellTumor Necrosis Factor-alpha
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.